Management of bleeding liver tumors

被引:26
作者
Darnis, B. [1 ]
Rode, A. [2 ]
Mohkam, K. [1 ]
Ducerf, C. [1 ]
Mabrut, J. -Y. [1 ]
机构
[1] Hosp Civils Lyon, Hop Croix Rousse, Serv Chirurg Gen & Digest Transplantat Hepat & In, F-69004 Lyon, France
[2] Hosp Civils Lyon, Hop Croix Rousse, Serv Radiol, F-69004 Lyon, France
关键词
Liver tumors; Hepatocellular carcinoma; Hepatic adenoma; Bleeding; Surgery; RUPTURED HEPATOCELLULAR-CARCINOMA; TRANSCATHETER ARTERIAL EMBOLIZATION; SINGLE-CENTER EXPERIENCE; HEPATIC ADENOMA; TRANSARTERIAL EMBOLIZATION; RESECTION; HEMOPERITONEUM; HEMORRHAGE; OUTCOMES; CHEMOEMBOLIZATION;
D O I
10.1016/j.jviscsurg.2014.05.007
中图分类号
R61 [外科手术学];
学科分类号
摘要
Liver tumors bleed rarely; management has changed radically during the last 20 years, advancing from emergency surgery with poor results to multidisciplinary management. The first steps are the diagnosis and control of bleeding. Abdominopelvic CT scan should be performed as soon as patient hemodynamics allow. When active bleeding is visualized, arterial embolization, targeted as selectively as possible, is preferable to surgery, which should be reserved for severe hemodynamic instability or failure of interventional radiology. When surgery is unavoidable, abbreviated laparotomy (damage control) with perihepatic packing is recommended. The second step is determination of the etiology and treatment of the underlying tumor. Adenoma and hepatocellular carcinoma (HCC) are the two most frequently encountered tumors in this context. Liver MRI after control of the bleeding episode generally leads to the diagnosis although sometimes the analysis can be difficult because of the hematoma. Prompt resection is indicated for HCC, atypical adenoma or lesions at risk for degeneration to hepatocellular carcinoma. For adenoma with no suspicion of malignancy, it is best to wait for the hematoma to resorb completely before undertaking appropriate therapy. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:365 / 375
页数:11
相关论文
共 70 条
  • [1] AMERIKS JA, 1975, ARCH SURG-CHICAGO, V110, P548
  • [2] [Anonymous], CANC STAGING MANUAL
  • [3] Prognostic Impact of Spontaneous Tumor Rupture in Patients With Hepatocellular Carcinoma An Analysis of 1160 Cases From a Nationwide Survey
    Aoki, Taku
    Kokudo, Norihiro
    Matsuyama, Yutaka
    Izumi, Namiki
    Ichida, Takafumi
    Kudo, Masatoshi
    Ku, Yonson
    Sakamoto, Michiie
    Nakashima, Osamu
    Matsui, Osamu
    Makuuchi, Masatoshi
    [J]. ANNALS OF SURGERY, 2014, 259 (03) : 532 - 542
  • [4] Management of ruptured hepatocellular carcinoma: Implications for therapy
    Bassi, Nicolo
    Caratozzolo, Ezio
    Bonariol, Luca
    Ruffolo, Cesare
    Bridda, Alessio
    Padoan, Luigi
    Antoniutti, Michele
    Massani, Marco
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (10) : 1221 - 1225
  • [5] Aetio-pathogenesis and the management of spontaneous liver bleeding in the West: a 16-year single-centre experience
    Battula, Narendra
    Tsapralis, Dimitrios
    Takhar, Arjun
    Coldham, Chris
    Mayer, David
    Isaac, John
    Muiesan, Paolo
    Sutcliffe, Robert P.
    Marudanayagam, Ravi
    Mirza, Darius F.
    Bramhall, Simon R.
    [J]. HPB, 2012, 14 (06) : 382 - 389
  • [6] Spontaneous rupture of hepatocellular carcinoma: a Western experience
    Battula, Narendra
    Madanur, Mansoor
    Priest, Oliver
    Srinivasan, Parthi
    O'Grady, John
    Heneghan, Michael A.
    Bowles, Matthew
    Muiesan, Paolo
    Heaton, Nigel
    Rela, Mohamed
    [J]. AMERICAN JOURNAL OF SURGERY, 2009, 197 (02) : 164 - 167
  • [7] RESECTION OF PRESUMED BENIGN LIVER-TUMORS
    BELGHITI, J
    PATERON, D
    PANIS, Y
    VILGRAIN, V
    FLEJOU, JF
    BENHAMOU, JP
    FEKETE, F
    [J]. BRITISH JOURNAL OF SURGERY, 1993, 80 (03) : 380 - 383
  • [8] Multidisciplinary management of ruptured hepatocellular carcinoma
    Buczkowski, AK
    Kim, PTW
    Ho, SG
    Schaeffer, DF
    Lee, SI
    Owen, DA
    Weiss, AH
    Chung, SW
    Scudamore, CH
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2006, 10 (03) : 379 - 386
  • [9] CHEARANAI O, 1983, CANCER-AM CANCER SOC, V51, P1532, DOI 10.1002/1097-0142(19830415)51:8<1532::AID-CNCR2820510829>3.0.CO
  • [10] 2-3